Skip to content

Clinical trials

Phase 2 Cognition Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognition Disorders Phase: Phase 2 Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20065
20072
20091
20102
20121
20131
20141
20151
20161
20181
20191
20202
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting3
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Washington3
National Institute of Mental Health (NIMH)2
University of Pennsylvania2
Antonia New1
AstraZeneca1
Center for Neurological Studies1
Cerecin1
Cognition Pharmaceuticals, LLC1
Duke University1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognition Disorders25
Cognitive Dysfunction11
Alzheimer Disease5
Schizophrenia4
HIV Infections3
Mental Disorders3
AIDS-Related Complex2
Acquired Immunodeficiency Syndrome2
Brain Diseases2
Brain Injuries, Traumatic2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.